Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cannabinoid receptor 2 (CB2), encoded by the CNR2 gene, is a class A G protein-coupled receptor (GPCR) that belongs to the endocannabinoid system. Unlike its counterpart CB1, which is predominantly expressed in the central nervous system, CB2 is primarily localized in peripheral tissues, particularly on immune cells such as B cells, T cells, macrophages, and microglia. It plays a critical role in modulating immune responses, inflammatory pathways, cell migration, and cytokine secretion. CB2 is highly inducible, with its expression levels dramatically increasing during tissue injury, inflammation, or neurodegenerative processes.\n\nConsequently, it has emerged as a promising therapeutic target for conditions such as neuropathic pain, chronic inflammation, autoimmune diseases, neurodegenerative disorders (e.g., Alzheimer's and Parkinson's diseases), and certain cancers. Pharmacological modulation of CB2 involves selective agonists (such as lenabasum and HU-308) and inverse agonists/antagonists (such as AM-630 and SR144528). A major therapeutic advantage of targeting CB2 over CB1 is the avoidance of the psychoactive and psychotropic side effects typically associated with CB1 activation. However, clinical translation has faced challenges, including species-specific differences in receptor binding, receptor desensitization, and maintaining high selectivity to prevent off-target CB1 activation.
Agonism, antagonism, and inverse agonism of the receptor to modulate downstream G-protein signaling pathways.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cannabinoid receptor 2 (CB2).